Actively Recruiting
Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
Led by Istanbul University · Updated on 2024-11-25
100
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing it to the results obtained from systematic lymphadenectomy, each performed in participants with a suspicious adnexal mass for early-stage ovarian cancer.
CONDITIONS
Official Title
Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must have a suspicious adnexal mass for early stage ovarian cancer
- Must be medically and surgically fit enough to perform SLNB and complete the systematic lymphadenectomy.
You will not qualify if you...
- Ovarian mass with low probability for early stage ovarian cancer
- Medical or surgical contraindications for surgical comprehensive staging
- Metastatic cancers or double primary cancers (metachronous) of ovary
- Recurrent ovarian cancer
- Preoperative or intraoperative finding of advanced ovarian cancer (FIGO stage III and IV)
- Neoadjuvant ovarian cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istanbul University
Istanbul, Turkey, Turkey (Türkiye), 34093
Actively Recruiting
Research Team
M
Mustafa ALBAYRAK, MD
CONTACT
Y
Yagmur MİNARECİ, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here